We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Life expectancy in many developed countries is 80 years and rising, but in some sub-Saharan African countries, it is 40 years and falling, mainly as a result of AIDS. These and many other inequities in global health are major ethical challenges in the world today.

Peter A. Singer and Abdullah S. Daar argue that, with decisive and timely action, genome-related biotechnology can be harnessed to improve global health equity.

They give examples of genome-related biotechnology being applied successfully to health problems in developing countries and propose a five-point strategy, including research, capacity strengthening, consensus building, public engagement, and an investment fund.

Link to full text

Reference: Science 294, 87 (2001)

Related topics